Search results
25 cze 2020 · Patients undergoing radiation therapy for head and neck cancer (HNC) experience significant early and long-term side effects. The likelihood and severity of complications depends on a number of factors, including the total dose of radiation delivered, over what time it was delivered and what parts of the head and neck received radiation.
- An Updated Review on Head and Neck Cancer Treatment with Radiation ...
The mainstay of treatment for locoregionally advanced head...
- An Updated Review on Head and Neck Cancer Treatment with Radiation ...
30 wrz 2021 · The mainstay of treatment for locoregionally advanced head and neck squamous cell carcinoma (HNSCC) is either surgery followed by adjuvant radiation therapy or definitive concurrent chemoradiation (CRT) reserving surgery as salvage therapy, referred to as the organ-preservation approach.
The purpose of this guideline is to provide contemporary recommendations for prevention, assessment, grading, and management of osteoradionecrosis (ORN) of the mandible and maxilla in patients with head and neck cancer (HNC) previously treated with head and neck radiation therapy (RT).
29 kwi 2022 · Patients with PD-L1–expressing metastatic head and neck squamous cell carcinoma should be treated with pembrolizumab or the combination of pembrolizumab and chemotherapy in the first line.
7 paź 2024 · 1 Introduction. Pain is highly prevalent in head and neck cancer (HNC) patients and is a major cause of morbidity in this population. Frequent pain assessment is critical to provide optimal patient care (Fink 2000).Pain assessment in clinical practice is often performed using questions describing the location, intensity, and quality of pain.
The most common presenting symptoms of head and neck cancers include dysphagia, odynophagia, otalgia, hoarseness, mucosal irregularities and ulceration, oral or oropharyngeal pain, weight loss, or the presence of an unexplained neck mass.
11 lis 2022 · This review will cover the latest advances in the oncology treatment available for patients with head and neck cancers, with a focus on how these might help reduce oral toxicity.
